Evotec Investor Day Presentation Deck slide image

Evotec Investor Day Presentation Deck

evotec Human PK and dose prediction • Multispecies prediction Improve quality and reduce costs to accelerate to INDs Development readiness: discovery to development continuum Target tissue concentration Continuum of predictions to optimise human PK during discovery process Predicting solid state • Design for solubility, polymorphism screening & crystallisation processes • Batch physical purity & crystal structure determination PAGE 82 Vein Portal Pancreas Gut t (faka) Spleen R Venous Blood Muscle Kidney R K Telt QTA CL Arterial Blood In Silico Relative Solubility Solvent Screening of Structure 1 @25°C Nared to the best solvent Predictive sciences drive faster and higher quality IND R Luno R Building development into Dx chemistry • >13,808 development transformations in a Dx reactions database Right First Time approach = no reengi- neering of process route for development Drug-induced liver injury Library of toxicology profiles • Integrated Al and machine learning to enhance predictive power Unrivalled mechanistic insight ● Action Ectrophilic reaction of 126 Aside formation R AI Alle An 11 SE X-OBLOm ->> GOPA Accuracy 78-82%
View entire presentation